Marco Montomoli

Burden of diagnosed and undetected hyperkalemia in Spain: Clinical characteristics, management, healthcare resource utilization, and costs

José Luis Górriz, Roberto Alcázar, Patricia de Sequera, Enrique Morales et autres

BACKGROUND: Management of hyperkalemia (HK) is challenging and suboptimal. This study analyzed the prevalence of HK and undetected HK, as well as management, clinical outcomes, healthcare resource utilization (HCRU), and costs. METHODS: Observational study comprising cross-sectional and retrospective analyses using secondary data …

es (code pays fourni par la source)

Urgent-start peritoneal dialysis: An alternative worth reconsidering

Marco Montomoli, Miguel González Rico, Boris Gonzalez Candia

Current and advanced therapeutic strategies for volume expansion management in heart failure

Miguel Lorenzo, Gonzalo Núñez-Marín, Marco Montomoli, Rafael de la Espriella et autres

INTRODUCTION: Congestion and/or volume expansion is primary driver of adverse outcomes in patients with heart failure. Despite the widespread use of loop diuretics as first-line therapy, diuretic resistance frequently limits effective decongestion. Consequently, alternative pharmacological and device-based strategies have emerged to address …

es, us (code pays fourni par la source)

Analysis of the carbon footprint of pharmacological treatments in advanced chronic kidney disease and peritoneal dialysis: Oral vs. subcutaneous administration

Susana Lomas-Calatayud, Francesc Moncho, Elena Giménez-Civera, María Jesús Puchades et autres

Background Carbon footprint quantification currently stands as the most accepted model for assessing the ecological impact of human activities. Selecting the most environmentally friendly treatment for pathologies arising from advanced chronic kidney disease can reduce the carbon footprint. Methods We aimed to …

es (code pays fourni par la source)

Chloride at the spotlight—but not alone: towards a multi-ionic diuretic strategy

Marco Montomoli, Maria Inês Roxo, Miguel González-Rico, J N Julio Nunez et autres

Diuretic resistance in heart failure and the cardiorenal syndrome is traditionally managed by escalating diuretic doses, yet this approach often fails to address the underlying pathophysiology. Emerging evidence challenges the sodium-centred paradigm and identifies chloride as a key determinant of diuretic responsiveness, …

es (code pays fourni par la source)

Impact of intravenous ferric carboxymaltose on physical performance and patient-reported outcomes in elderly patients with non-dialysis CKD, mild anemia, and iron deficiency: A pilot study

María Jesús Puchades, Juan Casas, J N Julio Nunez, Elena Giménez-Civera et autres

Iron deficiency (ID) is highly prevalent in chronic kidney disease (CKD) and it's associated with poorer quality of life (QoL) and functional capacity. Intravenous iron therapy is limited to CKD patients with ID and anemia to avoid/delay the need or reduce the …

es (code pays fourni par la source)

Analysis of the carbon footprint of pharmacological treatments in advanced chronic kidney disease and peritoneal dialysis: Oral vs. subcutaneous administration

Susana Lomas-Calatayud, Francesc Moncho, Elena Giménez-Civera, María Jesús Puchades et autres

BACKGROUND: Carbon footprint quantification currently stands as the most accepted model for assessing the ecological impact of human activities. Selecting the most environmentally friendly treatment for pathologies arising from advanced chronic kidney disease can reduce the carbon footprint. METHODS: We aimed to …

es (code pays fourni par la source)

Response to editorial comments - Manuscript: Multicenter validation of the Kidney Failure Risk Equation (KFRE) in Spanish patients with advanced chronic kidney disease

Marco Montomoli

es (code pays fourni par la source)

#1927 Clinical characteristics and healthcare resource utilization, and costs associated in patients with diagnosed and undetected hyperkalemia: IBERIK+ study

José Luis Górriz, Roberto Alcázar Arroyo, Patricia de Sequera Ortiz, Enrique Morales Ruiz et autres

Abstract Background and Aims Hyperkalemia (HK) is a common complication of chronic kidney disease (CKD) and heart failure (HF), particularly among patients receiving renin-angiotensin-aldosterone system inhibitors (RAASi). This study aimed to describe the clinical characteristics and healthcare resource utilization (HCRU) and costs …

es (code pays fourni par la source)

#1652 Clinical characteristics and healthcare resource utilization associated with mild, moderate and severe Hyperkalemia in Spain: IBERIK+ Study

Marco Montomoli, Patricia de Sequera Ortiz, Roberto Alcázar Arroyo, Miquel Blasco Pelícano et autres

Abstract Background and Aims Hyperkalemia (HK) is a frequent complication in patient with chronic kidney disease (CKD) and heart failure (HF), especially among those treated with renin-angiotensin-aldosterone system inhibitors (RAASi). This study aims to explore the clinical characteristics of these patients and …

es (code pays fourni par la source)

#1002 Spanish plan for hypertensive disorders in the puerperium: zero vascular and renal risk

Carolina Gracia-Iguacel, M A Dolores Del Pino Y Pino, Marta Arias Guillén, I. Albo Castaño et autres

Abstract Background and Aims Hypertensive disorders of pregnancy (HDP) are associated with increased postpartum risk of cardiovascular disease (CVD) or kidney failure. Given the change in the profile of the current pregnant woman (older age at pregnancy, obesity, diabetes, use of assisted …

es (code pays fourni par la source)

Impact of intravenous ferric carboxymaltose on physical performance and patient-reported outcomes in elderly patients with non-dialysis CKD, mild anemia, and iron deficiency: A pilot study

María Jesús Puchades, Juan Casas, Julio E. Núñez, Elena Giménez-Civera et autres

Background: Iron deficiency (ID) is highly prevalent in chronic kidney disease (CKD) and it’s associated with poorer quality of life (QoL) and functional capacity. Intravenous iron therapy is limited to CKD patients with ID and anemia to avoid/delay the need or reduce …

es (code pays fourni par la source)